There have been 50 recent insider transactions recorded for Fennec Pharmaceuticals Inc. (FENC), including 34 buys and 16 sells. Total insider buying was valued at $280.29K and total insider selling at $11.01M.
Notable insiders with recent activity include Raykov Rosty, Andrade Robert, Hackman Jeffrey S.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — FENC
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-01 |
Raykov Rosty |
Director |
Informative Sell |
10,946 |
$6.31 |
$69.07K |
113,856 |
| 2026-03-31 |
Andrade Robert |
Chief Financial Officer |
Option Exercise |
14,724 |
- |
- |
271,380 |
| 2026-03-31 |
Raykov Rosty |
Director |
RSU Award |
5,208 |
- |
- |
109,204 |
| 2026-03-31 |
Hackman Jeffrey S. |
Chief Executive Officer |
Option Exercise |
16,695 |
- |
- |
45,405 |
| 2026-03-31 |
Evans Terry L |
Chief Commercial Officer |
Option Exercise |
18,456 |
- |
- |
18,456 |
| 2026-03-31 |
Sayad Pierre Sargis |
Chief Medical Officer |
Option Exercise |
18,456 |
- |
- |
18,456 |
| 2026-03-31 |
Cioffi Christiana Marie |
Chief Strategy Officer |
Option Exercise |
17,106 |
- |
- |
21,806 |
| 2026-03-28 |
Andrade Robert |
Chief Financial Officer |
Option Exercise |
12,270 |
- |
- |
285,863 |
| 2026-03-28 |
Hackman Jeffrey S. |
Chief Executive Officer |
Option Exercise |
13,943 |
- |
- |
60,507 |
| 2026-03-28 |
Evans Terry L |
Chief Commercial Officer |
Option Exercise |
2,052 |
- |
- |
20,679 |
| 2026-03-28 |
Sayad Pierre Sargis |
Chief Medical Officer |
Option Exercise |
2,052 |
- |
- |
20,679 |
| 2026-03-28 |
Cioffi Christiana Marie |
Chief Strategy Officer |
Option Exercise |
1,901 |
- |
- |
23,865 |
| 2026-03-26 |
Andrade Robert |
Chief Financial Officer |
Option Exercise |
13,072 |
$5.10 |
$66.67K |
256,656 |
| 2026-03-26 |
Cioffi Christiana Marie |
Chief Strategy Officer |
Option Exercise |
4,700 |
$4.23 |
$19.88K |
4,700 |
| 2026-03-02 |
Raykov Rosty |
Director |
Informative Sell |
10,079 |
$8.36 |
$84.26K |
103,996 |
| 2026-02-28 |
Andrade Robert |
Chief Financial Officer |
RSU Award |
1,191 |
- |
- |
243,584 |
| 2026-02-28 |
Raykov Rosty |
Director |
RSU Award |
5,208 |
- |
- |
109,204 |
| 2026-02-18 |
Andrade Robert |
Chief Financial Officer |
Option Exercise |
2,450 |
$4.08 |
$10K |
215,108 |
| 2026-02-18 |
Hackman Jeffrey S. |
Chief Executive Officer |
Option Exercise |
13,710 |
- |
- |
28,710 |
| 2026-02-02 |
Raykov Rosty |
Director |
Informative Sell |
10,349 |
$7.76 |
$80.31K |
98,477 |
| 2026-01-31 |
Andrade Robert |
Chief Financial Officer |
RSU Award |
1,558 |
- |
- |
212,658 |
| 2026-01-31 |
Raykov Rosty |
Director |
RSU Award |
5,208 |
- |
- |
93,228 |
| 2026-01-23 |
Andrade Robert |
Chief Financial Officer |
Option Exercise |
10,000 |
$2.45 |
$24.5K |
211,100 |
| 2026-01-15 |
Andrade Robert |
Chief Financial Officer |
Option Exercise |
10,000 |
$2.45 |
$24.5K |
201,100 |
| 2026-01-07 |
Andrade Robert |
Chief Financial Officer |
Option Exercise |
14,184 |
$2.45 |
$34.75K |
191,100 |
| 2026-01-02 |
Raykov Rosty |
Director |
Informative Sell |
10,312 |
$7.60 |
$78.37K |
88,020 |
| 2025-12-31 |
Andrade Robert |
Chief Financial Officer |
RSU Award |
1,382 |
- |
- |
176,916 |
| 2025-12-31 |
Raykov Rosty |
Director |
RSU Award |
5,208 |
- |
- |
82,734 |
| 2025-12-24 |
Southpoint Capital Advisors Lp |
10 Percent Owner |
Informative Sell |
1,000,000 |
$7.50 |
$7.5M |
2,744,741 |
| 2025-12-05 |
Raykov Rosty |
Director |
Informative Sell |
10,000 |
$7.54 |
$75.4K |
77,526 |
| 2025-12-01 |
Andrade Robert |
Chief Financial Officer |
RSU Award |
2,430 |
- |
- |
175,534 |
| 2025-12-01 |
Raykov Rosty |
Director |
RSU Award |
5,208 |
- |
- |
87,526 |
| 2025-11-18 |
Southpoint Capital Advisors Lp |
10 Percent Owner |
Informative Sell |
19,341 |
$8.79 |
$170.05K |
3,744,741 |
| 2025-11-17 |
Southpoint Capital Advisors Lp |
10 Percent Owner |
Informative Sell |
85,918 |
$8.79 |
$755.19K |
3,764,082 |
| 2025-11-14 |
Southpoint Capital Advisors Lp |
10 Percent Owner |
Informative Sell |
160,100 |
$8.00 |
$1.28M |
3,850,000 |
| 2025-11-05 |
Raykov Rosty |
Director |
Informative Sell |
10,000 |
$8.10 |
$81K |
82,318 |
| 2025-10-31 |
Andrade Robert |
Chief Financial Officer |
RSU Award |
2,430 |
- |
- |
173,104 |
| 2025-10-31 |
Raykov Rosty |
Director |
RSU Award |
5,208 |
- |
- |
92,318 |
| 2025-10-10 |
Rallis Chris A |
Director |
Informative Sell |
1,775 |
$9.24 |
$16.4K |
57,079 |
| 2025-10-09 |
Southpoint Capital Advisors Lp |
10 Percent Owner |
Informative Sell |
20,609 |
$9.35 |
$192.61K |
4,010,100 |
| 2025-10-08 |
Raykov Rosty |
Director |
Option Exercise |
4,609 |
$2.45 |
$11.29K |
87,110 |
| 2025-10-08 |
Southpoint Capital Advisors Lp |
10 Percent Owner |
Informative Sell |
19,605 |
$9.47 |
$185.72K |
4,030,709 |
| 2025-10-07 |
Southpoint Capital Advisors Lp |
10 Percent Owner |
Informative Sell |
26,900 |
$9.59 |
$257.89K |
4,050,314 |
| 2025-10-06 |
Raykov Rosty |
Director |
Informative Sell |
10,000 |
$9.78 |
$97.8K |
82,501 |
| 2025-09-30 |
Andrade Robert |
Chief Financial Officer |
RSU Award |
2,430 |
- |
- |
170,674 |
| 2025-09-30 |
Raykov Rosty |
Director |
RSU Award |
5,208 |
- |
- |
92,501 |
| 2025-09-05 |
Raykov Rosty |
Director |
Option Exercise |
36,207 |
$2.45 |
$88.71K |
87,293 |
| 2025-09-04 |
Raykov Rosty |
Director |
Informative Sell |
10,000 |
$8.92 |
$89.2K |
51,086 |
| 2025-08-31 |
Andrade Robert |
Chief Financial Officer |
RSU Award |
2,431 |
- |
- |
168,244 |
| 2025-08-31 |
Raykov Rosty |
Director |
RSU Award |
5,208 |
- |
- |
61,086 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
